249 related articles for article (PubMed ID: 10605713)
1. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
Doolittle RF; Spraggon G; Everse SJ
Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
[No Abstract] [Full Text] [Related]
2. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
Doolittle RF; Pandi L
Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
Spraggon G; Everse SJ; Doolittle RF
Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide.
Everse SJ; Spraggon G; Veerapandian L; Doolittle RF
Biochemistry; 1999 Mar; 38(10):2941-6. PubMed ID: 10074346
[TBL] [Abstract][Full Text] [Related]
5. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
6. Fibrin degradation products. A review of structures found in vitro and in vivo.
Gaffney PJ
Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
[TBL] [Abstract][Full Text] [Related]
7. The structure of soluble fibrin oligomers.
Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
Dokl Biochem Biophys; 2011; 440():203-6. PubMed ID: 22095118
[No Abstract] [Full Text] [Related]
8. Structure and function of fibrinogen: insights from dysfibrinogens.
Matsuda M; Sugo T; Yoshida N; Terukina S; Yamazumi K; Niwa K; Maekawa H
Thromb Haemost; 1999 Aug; 82(2):283-90. PubMed ID: 10605715
[TBL] [Abstract][Full Text] [Related]
9. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
[TBL] [Abstract][Full Text] [Related]
10. B beta Glu397 and B beta Asp398 but not B beta Asp432 are required for "B:b" interactions.
Kostelansky MS; Bolliger-Stucki B; Betts L; Gorkun OV; Lord ST
Biochemistry; 2004 Mar; 43(9):2465-74. PubMed ID: 14992584
[TBL] [Abstract][Full Text] [Related]
11. Calcium dependence of fibrin nanomechanics: the γ1 calcium mediates the unfolding of fibrinogen induced by force applied to the "A-a" bond.
Averett LE; Akhremitchev BB; Schoenfisch MH; Gorkun OV
Langmuir; 2010 Sep; 26(18):14716-22. PubMed ID: 20731339
[TBL] [Abstract][Full Text] [Related]
12. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen and fibrin polymerization and functions.
Mosesson MW
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S45-8. PubMed ID: 10070818
[No Abstract] [Full Text] [Related]
14. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
Pozdniakova TM; Rybachuk VN; Vovk EV
Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
[TBL] [Abstract][Full Text] [Related]
16. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
[TBL] [Abstract][Full Text] [Related]
17. [Biologically active low-molecular fragments of fibrinogen molecule].
Musialkivs'ka AO; Platonova TM; Radavs'kiĭ IuL
Ukr Biokhim Zh; 1977; 49(3):89-93. PubMed ID: 888231
[TBL] [Abstract][Full Text] [Related]
18. A three-dimensional consideration of variant human fibrinogens.
Everse SJ; Spraggon G; Doolittle RF
Thromb Haemost; 1998 Jul; 80(1):1-9. PubMed ID: 9684777
[TBL] [Abstract][Full Text] [Related]
19. Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products.
Nieuwenhuizen W; van Ruijven-Vermeer IA; Nooijen WJ; Vermond A; Haverkate F; Hermans J
Thromb Res; 1981 Jun 1-25; 22(5-6):653-7. PubMed ID: 7302909
[No Abstract] [Full Text] [Related]
20. Calcium-binding site beta 2, adjacent to the "b" polymerization site, modulates lateral aggregation of protofibrils during fibrin polymerization.
Kostelansky MS; Lounes KC; Ping LF; Dickerson SK; Gorkun OV; Lord ST
Biochemistry; 2004 Mar; 43(9):2475-83. PubMed ID: 14992585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
